FIELD: chemical-pharmaceutical industry. SUBSTANCE: invention proposes agent as liquid or soft medicinal form containing cytokin taken at effective amount has additionally glycerol at amount 10-90 wt.-%. Claimed agent can contain recombinant interferon at amount 103-107 IU/1 g of agent and/or recombinant tumor necrosis α-factor at amount 103-107 IU/1 g of agent as cytokin. Claimed agent can contain additionally immunoglobulins at amount 1-60 wt.-%, among them as the mixture of IgA, IgG and IgM. EFFECT: increased preservation of cytokin activity in drug, enhanced effectiveness of its curative effect. 4 cl
Title | Year | Author | Number |
---|---|---|---|
CRYOPROTECTIVE OINTMENT | 2004 |
|
RU2251430C1 |
BIOLOGICALLY ACTIVE ADDITION | 2000 |
|
RU2164765C1 |
CRYOPROTECTIVE PREPARATION | 2004 |
|
RU2251431C1 |
FOOD BIOLOGICALLY ACTIVE ADDITION | 1999 |
|
RU2144294C1 |
BIOLOGICALLY-ACTIVE FOOD ADDITIVE | 2000 |
|
RU2157646C1 |
METHOD OF DETERMINATION OF MICROBE SENSITIVITY TO ANTIBIOTIC | 1997 |
|
RU2121678C1 |
METHOD OF PREPARING IMMUNOGLOBULIN PREPARATION CONTAINING RECOMBINANT ALPHA-2-INTERFERON | 1997 |
|
RU2116083C1 |
ANTIVIRAL AND ANTIMICROBIAL ORAL COMPOSITION | 2008 |
|
RU2457856C2 |
METHOD OF TREATING CHRONIC PAIN SYNDROME | 2014 |
|
RU2545915C1 |
BIOLOGICALLY-ACTIVE ADDITIVE | 2000 |
|
RU2161887C1 |
Authors
Dates
2000-01-27—Published
1999-05-17—Filed